These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8252271)

  • 1. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis.
    Park KG; Blessing K; McLaren KM; Watson AC
    Br J Plast Surg; 1993 Oct; 46(7):607-10. PubMed ID: 8252271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.
    Blessing K; McLaren KM; McLean A; Davidson P
    Histopathology; 1990 Nov; 17(5):389-95. PubMed ID: 2076865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of level and depth on recurrence rate in thin melanomas.
    Pontikes LA; Temple WJ; Cassar SL; Lafrenière R; Huchcroft SA; Jerry LM; Alexander F; Marx LH
    Am J Surg; 1993 Feb; 165(2):225-8. PubMed ID: 8427401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
    Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2002 Jul; 147(1):48-54. PubMed ID: 12100184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loco-regional renewal of malignant melanomas. I. Local recurrence satellites and in-transit nodes.
    Lukács L
    Acta Chir Hung; 1992-1993; 33(3-4):325-34. PubMed ID: 1345392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
    Milton GW; Shaw HM; Farago GA; McCarthy WH
    Br J Surg; 1980 Aug; 67(8):543-6. PubMed ID: 7427045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in patients with thin malignant melanoma: influence of regression.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):673-80. PubMed ID: 6629343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy and survival of malignant melanoma.
    Rampen FH; van der Esch EP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):385-8. PubMed ID: 3973139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
    Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
    Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognosis and disease progression after local recurrence of melanoma.
    Dong XD; Tyler D; Johnson JL; DeMatos P; Seigler HF
    Cancer; 2000 Mar; 88(5):1063-71. PubMed ID: 10699896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
    Griffiths RW; Briggs JC
    Br J Plast Surg; 1984 Oct; 37(4):507-13. PubMed ID: 6498389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.
    Tas F; Erturk K
    Clin Transl Oncol; 2018 May; 20(5):607-612. PubMed ID: 28948477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence and metastasis of thin malignant melanomas (less than or equal to 1mm)].
    Garbe C; Stadler R; Orfanos CE
    Hautarzt; 1989 Jun; 40(6):337-43. PubMed ID: 2753709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome.
    Hunger RE; Seyed Jafari SM; Angermeier S; Shafighi M
    Br J Dermatol; 2014 Dec; 171(6):1391-6. PubMed ID: 25392906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.
    Baer SC; Schultz D; Synnestvedt M; Elder DE
    Cancer; 1995 Dec; 76(11):2242-7. PubMed ID: 8635027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.